Seagen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Seagen and buy or sell other stocks, ETFs, and their options commission-free!

About SGEN

Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. 

CEO
David R. Epstein, MBA
CEODavid R. Epstein, MBA
Employees
Employees
Headquarters
Bothell, Washington
HeadquartersBothell, Washington
Founded
1997
Founded1997
Employees
Employees

SGEN Key Statistics

Market cap
39.20B
Market cap39.20B
Price-Earnings ratio
-57.10
Price-Earnings ratio-57.10
Dividend yield
Dividend yield
Average volume
3.45M
Average volume3.45M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$228.96
52 Week high$228.96
52 Week low
$123.77
52 Week low$123.77

Stock Snapshot

With a market cap of 39.2B, Seagen(SGEN) trades at $228.74. The stock has a price-to-earnings ratio of -57.10.

During the trading day, Seagen(SGEN) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 3.45M.

Over the past 52 weeks, Seagen(SGEN) stock has traded between a high of $228.96 and a low of $123.77.

Over the past 52 weeks, Seagen(SGEN) stock has traded between a high of $228.96 and a low of $123.77.

People also own

Based on the portfolios of people who own SGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.